Naba Al Saha Medical Services Company (TADAWUL:9546)
Saudi Arabia · Delayed Price · Currency is SAR 23.00
+1.00 (4.55%)
Oct 15, 2026, 2:30 PM AST
TADAWUL:9546 Ratios and Metrics
Market cap in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 483 | 515 | 830 | 630 | 301 | - | |
Market Cap Growth | -23.27% | -37.97% | 31.67% | 109.30% | - | - |
Enterprise Value | 612 | 596 | 874 | 650 | 319 | - |
Last Close Price | 23.00 | 24.50 | 39.35 | 29.88 | 14.22 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 16.92 | 18.69 | 38.08 | 12.03 | 11.18 | - |
PS Ratio | 2.34 | 2.55 | 4.27 | 3.46 | 2.32 | - |
PB Ratio | 2.03 | 2.31 | 4.16 | 3.50 | 2.32 | - |
P/TBV Ratio | 2.06 | 2.35 | 4.23 | 3.56 | 2.37 | - |
P/FCF Ratio | - | - | - | - | 10.77 | - |
P/OCF Ratio | 21.14 | 19.20 | 23.28 | 21.46 | 8.48 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.97 | 2.95 | 4.50 | 3.57 | 2.46 | - |
EV/EBITDA Ratio | 13.75 | 14.15 | 25.44 | 12.62 | 9.12 | - |
EV/EBIT Ratio | 18.63 | 18.42 | 34.60 | 14.83 | 10.71 | - |
EV/FCF Ratio | - | - | - | - | 11.42 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.68 | 0.55 | 0.45 | 0.27 | 0.17 | 0.32 |
Debt / EBITDA Ratio | 3.57 | 2.80 | 2.48 | 0.91 | 0.60 | 0.98 |
Debt / FCF Ratio | - | - | - | - | 0.79 | 1.63 |
Net Debt / Equity Ratio | 0.54 | 0.47 | 0.23 | 0.24 | 0.06 | 0.26 |
Net Debt / EBITDA Ratio | 2.98 | 2.46 | 1.35 | 0.82 | 0.24 | 0.81 |
Net Debt / FCF Ratio | -3.50 | -2.40 | -25.38 | -4.46 | 0.30 | 1.29 |
Asset Turnover | 0.53 | 0.57 | 0.65 | 0.82 | 0.79 | 0.78 |
Inventory Turnover | 13.93 | 15.65 | 14.00 | 14.30 | 14.20 | 13.49 |
Quick Ratio | 5.59 | 5.59 | 5.93 | 2.45 | 3.48 | 2.58 |
Current Ratio | 6.24 | 6.26 | 6.62 | 2.75 | 3.80 | 2.89 |
Return on Equity (ROE) | 12.72% | 13.03% | 11.47% | 33.78% | 23.12% | 28.50% |
Return on Assets (ROA) | 5.32% | 5.70% | 5.25% | 12.25% | 11.34% | 11.46% |
Return on Invested Capital (ROIC) | 8.36% | 10.15% | 9.38% | 23.20% | 20.74% | 20.46% |
Return on Capital Employed (ROCE) | 8.00% | 8.90% | 8.40% | 19.00% | 19.90% | 21.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 5.91% | 5.35% | 2.63% | 8.31% | 8.94% | - |
FCF Yield | -7.63% | -8.40% | -0.22% | -1.51% | 9.29% | - |
Dividend Yield | 0.65% | - | 0.38% | - | 0.70% | - |
Payout Ratio | - | 11.44% | - | 4.01% | 7.80% | - |
Total Shareholder Return | 0.65% | - | 0.38% | - | 0.70% | - |